In highly immunogenic GL261-quad mouse glioma models, infection with TMEV–OVA intracranially or intraperitoneally could significantly increase OVA-specific CD8+ T-cell populations compared to wild-type TMEV infection. This evidence concerns the gene CD8A and glioma.